Sort
40,608 grants matching “prostate cancer”
The Radium-223 Combination Therapy Space; Improving Response and Clarifying Toxicities
$429,037Daniel Lyndon Jaffe Thorek · Washington University · R01 · FY2023 · CA
Development of SHP2 inhibitors for targeted anti-cancer therapy
$429,035Zhong-Yin Zhang · Purdue University · R01 · FY2021 · CA
Engineering Natural Killer Cells to Target Acute Myeloid Leukemia with HLA-DR Loss
$429,000Jianming Xie · Western University Of Health Sciences · R15 · FY2025 · CA
Targeting the PI3K Signaling Axis
$428,993Thomas M Roberts · Massachusetts General Hospital · P50 · FY2017 · CA
The influence of selenium on biomarkers of prostate cancer risk
$428,977Karam E El-Bayoumy · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2009 · CA
Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis
$428,881David S. Rickman · Weill Medical Coll Of Cornell Univ · R01 · FY2014 · CA
Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis
$428,881David S. Rickman · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · CA
Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis
$428,881David S. Rickman · Weill Medical Coll Of Cornell Univ · R01 · FY2017 · CA
Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis
$428,881David S. Rickman · Weill Medical Coll Of Cornell Univ · R01 · FY2015 · CA
Mechanistic Insights Underlying ERG-induced Taxane Resistance in Castration-Resis
$428,881David S. Rickman · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · CA
Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens
$428,829Daniel William Cramer · Brigham And Women'S Hospital · R01 · FY2015 · CA
Studies of Non-Ionizing Radiation-Related Cancer
$428,758Elizabeth Cahoon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA
Statistical Methods for Medical Tests and Biomarkers
$428,749Margaret S. Pepe · Fred Hutchinson Cancer Research Center · R01 · FY2010 · GM
Functional Determinants of Metastatic Dormancy
$428,739Julio A Aguirre-Ghiso · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · CA
A non-canonical role for EZH2 in rRNA methtlation
$428,722Qi Cao · Northwestern University At Chicago · R01 · FY2025 · CA
Enhanced imaging and treatment of aggressive subtypes of prostate cancer
$428,718Martin G Pomper · Ut Southwestern Medical Center · R01 · FY2024 · CA
Human and Computer Mentors for Prostate Cancer Patients
$428,713Robert P Hawkins · University Of Wisconsin-Madison · R01 · FY2006 · CA
Integrating Epigenomic and Nuclear Receptor Signaling in Castrate Resistant Prostate Cancer
$428,683Debabrata Chakravarti · Northwestern University At Chicago · R01 · FY2019 · CA
Project 4: The BRCA Network in Medulloblastoma Responses to Replication Stress
$428,616Zhiyuan Shen · Rbhs -Cancer Institute Of New Jersey · P01 · FY2021 · CA
Epidemiologic and Basic Science in Cancer Prevention
$428,558James Marshall · Roswell Park Cancer Institute Corp · R25 · FY2007 · CA
Glucocorticoid Receptor Transcriptional Activity and the Evolution of Enzalutamide-Resistant CRPC
$428,492Russell Z Szmulewitz · Northwestern University At Chicago · P50 · FY2015 · CA
p53 Variants in Cancer Risk and Therapy
$428,330Maureen E Murphy · Wistar Institute · R01 · FY2018 · CA
Heparan Sulfate--a Novel Target for Cancer Therapeutics
$428,329University Of California San Diego · U01 · FY2002 · CA
The influence of selenium on biomarkers of prostate cancer risk
$428,328Karam E El-Bayoumy · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2008 · CA
Targeting chemoresistant prostate cancer with novel EED inhibitors
$428,304Daqing Wu · Clark Atlanta University · R01 · FY2025 · CA